Haleon Plc publishes 2024 Annual Report

GSK

Haleon plc (LON:HLN) has published its Annual Report and Form 20-F for the year ended 31 December 2024.

The Annual Report is publicly available on the Company’s website at http://www.haleon.com/investors/annual-report-2024.

In compliance with the Disclosure Guidance and Transparency Rules, the Annual Report, as submitted to the National Storage Mechanism, contains regulated information in unedited full text and is available on the Company’s website as noted above.

Shareholders may request a hard copy of the Annual Report, including the complete audited financial statements of the Company. Requests should be directed to: Company Secretariat, Haleon plc, Building 5, First Floor, The Heights, Weybridge, KT13 0NY, United Kingdom or to corporate.secretariat@haleon.com.

The Company’s Annual General Meeting (“AGM”) will take place on 28 May 2025. The Notice of AGM will be published and distributed to shareholders in due course.

Share on:

Latest Company News

Haleon appoints Vindi Banga as new Chair as Sir Dave Lewis steps down

Haleon has confirmed that Sir Dave Lewis will step down as Chair at the end of December 2025, with Vindi Banga appointed to take over from January 2026.

Haleon delivers 3.4% organic revenue growth in Q3 2025 driven by oral health and VMS

Haleon reported Q3 2025 revenue of £2.8 billion, reflecting 3.4% organic growth, led by strong performances in Oral Health and Vitamins, Minerals and Supplements.

Haleon Plc Q1 2025: £2.85bn revenue, 3.5% organic growth

Haleon plc has released its Q1 trading statement for 2025, with a presentation and Q&A session led by CFO Dawn Allen scheduled for April 30.

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now.

Haleon Plc reports strong Q3 organic revenue growth, guidance reaffirmed

Haleon plc releases its Q3 2024 trading update, now available for review. Join the presentation on October 31 for in-depth analysis and insights.

Haleon plc Reports Resilient Q1 2024 Performance Despite Market Challenges

Haleon plc (NYSE/LON:HLN) impresses with solid Q1 results, showcasing organic revenue growth despite market challenges. Explore key sectors and financial highlights here. #Haleon #ConsumerHealth

    Search

    Search